Objectives: Cardiovascular disease (CVD) is the leading cause of mortality in New Zealand with a disproportionate burden of disease in the Māori population. The Hauora Manawa Project investigated the prevalence of cardiovascular risk factors and CVD in randomly selected Māori and non-Māori participants. This paper reports the prevalence of structural changes in the heart.Methods: A total of 252 rural Māori, 243 urban Māori; and 256 urban non-Māori underwent echocardiography to assess cardiac structure and function. Multivariable logistic regression was used to determine variables associated with heart size.Results: Left ventricular (LV) mass measurements were largest in the rural Māori cohort (183.5,sd 61.4), intermediate in the urban Māori...
Left-ventricular hypertrophy (LVH) is a cardinal manifestation of hypertensive organ damage associat...
ObjectiveThe purpose of this study was to evaluate the relationship of left ventricular (LV) mass an...
Romel Bacchus, Kristianna Singh, Ijaz Ogeer, Kameel MungrueDepartment Paraclinical Sciences, Public ...
Objectives: Cardiovascular disease (CVD) is the leading cause of mortality in New Zealand with a dis...
Māori, the indigenous population of New Zealand (NZ), have poorer cardiovascular health outcomes com...
The prevalence of and risk factors associated with echocardiographically determined left ventricular...
Background Left ventricular hypertrophy (LVH) is frequently seen in association with arterial hypert...
Objective: Indo-Asians have one of the highest rates of cardiovascular disease worldwide. Estimates ...
ObjectivesHypertension is the key modifiable cardiovascular risk factor but is underdiagnosed, and i...
In New Zealand, cardiovascular disease is higher among Maori and Pacific peoples than other ethnic ...
Objectives: To document levels of cardiovascular disease (CVD), diagnosed and undiagnosed risk facto...
Background there are considerable regional disparities in the prevalence of cardiovascular risk fact...
Left ventricular hypertrophy (LVH) has prognostic significance on cardiovascular mortality and morbi...
AIM: We sought to evaluate new-onset abnormal LV (left ventricle) patterns and their correlates ov...
INTRODUCTION: Left ventricular hypertrophy (LVH) is a major and independent risk factor for cardiova...
Left-ventricular hypertrophy (LVH) is a cardinal manifestation of hypertensive organ damage associat...
ObjectiveThe purpose of this study was to evaluate the relationship of left ventricular (LV) mass an...
Romel Bacchus, Kristianna Singh, Ijaz Ogeer, Kameel MungrueDepartment Paraclinical Sciences, Public ...
Objectives: Cardiovascular disease (CVD) is the leading cause of mortality in New Zealand with a dis...
Māori, the indigenous population of New Zealand (NZ), have poorer cardiovascular health outcomes com...
The prevalence of and risk factors associated with echocardiographically determined left ventricular...
Background Left ventricular hypertrophy (LVH) is frequently seen in association with arterial hypert...
Objective: Indo-Asians have one of the highest rates of cardiovascular disease worldwide. Estimates ...
ObjectivesHypertension is the key modifiable cardiovascular risk factor but is underdiagnosed, and i...
In New Zealand, cardiovascular disease is higher among Maori and Pacific peoples than other ethnic ...
Objectives: To document levels of cardiovascular disease (CVD), diagnosed and undiagnosed risk facto...
Background there are considerable regional disparities in the prevalence of cardiovascular risk fact...
Left ventricular hypertrophy (LVH) has prognostic significance on cardiovascular mortality and morbi...
AIM: We sought to evaluate new-onset abnormal LV (left ventricle) patterns and their correlates ov...
INTRODUCTION: Left ventricular hypertrophy (LVH) is a major and independent risk factor for cardiova...
Left-ventricular hypertrophy (LVH) is a cardinal manifestation of hypertensive organ damage associat...
ObjectiveThe purpose of this study was to evaluate the relationship of left ventricular (LV) mass an...
Romel Bacchus, Kristianna Singh, Ijaz Ogeer, Kameel MungrueDepartment Paraclinical Sciences, Public ...